Visit-to-Visit Variability in Lipid Levels and Risk of Incident Heart Failure in Adults With Type 2 Diabetes [0.03%]
血脂水平逐访变异性和2型糖尿病成年人新发心力衰竭的风险关系
Arnaud D Kaze,Chiadi E Ndumele,Seth S Martin et al.
Arnaud D Kaze et al.
Objective: Limited data exist on the relation between long-term variability in blood lipid fractions and incident heart failure (HF) in the setting of type 2 diabetes mellitus (T2DM). ...
Subphenotype-Dependent Benefits of Bariatric Surgery for Individuals at Risk for Type 2 Diabetes [0.03%]
代谢手术对不同前期糖尿病亚表型患者的影响差异
Leontine Sandforth,Violeta Raverdy,Arvid Sandforth et al.
Leontine Sandforth et al.
Objective: Bariatric surgery is an effective treatment option for individuals with obesity and type 2 diabetes (T2D). However, whether outcomes in subtypes of individuals at risk for T2D and/or comorbidities (Tübingen Cl...
Risk of Adverse Pregnancy Outcomes Among Asian Individuals With Gestational Diabetes Mellitus in the U.S., 2016-2021 [0.03%]
2016至2021年美国亚裔妊娠期糖尿病患者不良妊娠结局的风险
Kartik K Venkatesh,Xiaoning Huang,Nilay S Shah et al.
Kartik K Venkatesh et al.
Objective: The risk of adverse pregnancy outcomes (APOs) differs among race and ethnic groups with gestational diabetes mellitus (GDM). Heterogeneity in APOs may be masked by aggregating these groups. We assessed whether ...
M120 Risk Score Improves Identification of Children at High Risk of Developing Clinical Type 1 Diabetes and Reports Short-Term Response to Preventive Immunotherapy [0.03%]
M120风险评分可改善高危儿童临床1型糖尿病的识别，并报告预防性免疫疗法的短期反应
Minh V Le,Leonard C Harrison,Tim Spelman et al.
Minh V Le et al.
Objective: Approval of teplizumab as disease-modifying therapy for type 1 diabetes heralds a new therapeutic era. To facilitate prevention trials, we determined if the M120 risk score could enrich for type 1 diabetes risk...
Effect of Marked Weight Loss on Adipose Tissue Biology in People With Obesity and Type 2 Diabetes [0.03%]
体重减轻对肥胖和2型糖尿病患者脂组织生物学的影响
Dmitri Samovski,Gordon I Smith,Hector Palacios et al.
Dmitri Samovski et al.
Objective: Weight loss improves insulin sensitivity in people with obesity and type 2 diabetes. However, the mechanisms responsible for this effect are unclear. We hypothesized that alterations in adipose tissue biology a...
Association of Patient Cost-Sharing With Adherence to GLP-1a and Adverse Health Outcomes [0.03%]
患者自付费用与GLP-1a依从性及不良健康结果的关联研究
Donglan Zhang,Nihan Gencerliler,Amrita Mukhopadhyay et al.
Donglan Zhang et al.
Objective: To examine the associations between patient out-of-pocket (OOP) costs and nonadherence to glucagon-like peptide 1 receptor agonists (GLP-1a), and the consequent impact on adverse outcomes, including hospitaliza...
A Comparative Analysis of Glycemic Metrics Derived From Three Continuous Glucose Monitoring Systems [0.03%]
三种动态血糖监测系统衍生的血糖计量指标比较分析
Guido Freckmann,Stephanie Wehrstedt,Manuel Eichenlaub et al.
Guido Freckmann et al.
Objective: This study analyzed the differences in continuous glucose monitoring (CGM)-derived metrics among three current-generation systems and evaluated their impact on therapeutic decision-making. ...
Ruijie Xie,Tomislav Vlaski,Kira Trares et al.
Ruijie Xie et al.
Objective: This study evaluated the incremental predictive value of proteomic biomarkers in assessing 10-year type 2 diabetes risk when added to the clinical Cambridge Diabetes Risk Score (CDRS). ...
Lack of Validity of the Glucose Management Indicator in Type 1 Diabetes in Pregnancy [0.03%]
妊娠期1型糖尿病患者糖化血红蛋白不可用的原因分析
Claire L Meek,Denice S Feig,Eleanor M Scott et al.
Claire L Meek et al.
Objective: The glucose management indicator (GMI) is widely used as a replacement for HbA1c, but information in pregnancy is very limited. We assessed the accuracy of GMI and associations with pregnancy outcomes in type 1...
Risk of Urogenital Infections in People With Type 2 Diabetes Initiating SGLT2i Versus GLP-1RA in Routine Clinical Care: A Danish Cohort Study [0.03%]
与GLP-1受体激动剂相比，丹麦队列研究中关于接受SGLT-2抑制剂治疗的2型糖尿病患者泌尿生殖系统感染的风险临床护理常规中的风险：一项丹麦队列研究
Christine Ljungberg,Frederik Pagh Bredahl Kristensen,Michael Dalager-Pedersen et al.
Christine Ljungberg et al.
Objective: Anticipated risks of urinary tract infections (UTI) and genital tract infections (GTI) associated with sodium-glucose cotransporter 2 inhibitors (SGLT2i) may prevent their use in clinical practice. We investiga...